<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">MEDICATIONS</a></li><li><a href="#id2">PROBLEMS</a></li><li><a href="#id3">VITAL SIGNS</a></li><li><a href="#id4">Encounters</a></li><li><a href="#id5">ASSESSMENTS</a></li><li><a href="#id6">PLAN OF TREATMENT</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">MEDICATIONS</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Omeprazole 20 MG</td><td ID="instruction1">TAKE 1 CAPSULE BY MOUTH EVERY DAY 30 MINUTES BEFORE BREAKFAST for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Losartan Potassium 100 MG</td><td ID="instruction2">1 tablet Orally Once a day for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication3">Glimepiride 4 MG</td><td ID="instruction3">TAKE 1 TABLET BY MOUTH TWICE DAILY for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Doxazosin Mesylate 4 MG</td><td ID="instruction4">TAKE 1 TABLET BY MOUTH EVERY DAY for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">amLODIPine Besylate 5 MG</td><td ID="instruction5">TAKE 1 TABLET BY MOUTH EVERY DAY for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Atorvastatin Calcium 40 MG</td><td ID="instruction6">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">TRUEplus Lancets 33G -</td><td ID="instruction7">TEST THREE TIMES DAILY as directed for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication8">True Metrix Blood Glucose Test -</td><td ID="instruction8">use as directed Three times a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Albuterol Sulfate HFA 108 (90 Base) MCG/ACT</td><td ID="instruction9">2 puff as needed Inhalation every 4 hrs for 30 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication10">Triamcinolone Acetonide 0.1 %</td><td ID="instruction10">1 application Externally once a day for 30 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication11">NovoLIN 70/30 ReliOn (70-30) 100 UNIT/ML</td><td ID="instruction11">10u Subcutaneous once a day</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication12">Insulin Syringe 31G X 5/16" 1 ML</td><td ID="instruction12">as directed injection once a day for 90</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication13">True Metrix Meter w/Device</td><td ID="instruction13">as directed as directed for 90 days</td><td ID="medication13notes">dx e11.9</td><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication14">Levothyroxine Sodium 75 MCG</td><td ID="instruction14">TAKE 1 TABLET EVERY MORNING ON AN EMPTY STOMACH for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication15">Aspirin 81 MG</td><td ID="instruction15">1 tablet Orally Once a day for 30 day(s)</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">PROBLEMS</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>SNOMED Code</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td ID="Problem1">Chronic kidney disease, stage 3 (moderate) (N18.3)</td><td/><td>Active</td><td>confirmed</td><td/><td>Chronic kidney disease stage 3 (disorder) (433144002)</td><td/></tr><tr><td>Problem</td><td ID="Problem2">Type 2 diabetes mellitus with diabetic neuropathy, unspecified (E11.40)</td><td/><td>Active</td><td>confirmed</td><td/><td>Diabetic peripheral neuropathy associated with type 2 diabetes mellitus (1511000119107)</td><td/></tr></tbody></table></div><h3><a name="id3" href="#toc">VITAL SIGNS</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>97.1 degrees Fahrenheit</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Heart Rate</th><td>60 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital3">Height</th><td>72 in</td><td>[REDACTED]</td></tr><tr><th ID="vital4">Weight</th><td>198 lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Oximetry</th><td>97 %</td><td>[REDACTED]</td></tr><tr><th ID="vital6">BMI</th><td>26.85 kg/m2</td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>[REDACTED] MD PA</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Type 2 diabetes mellitus with hyperglycemia E11.65 ; Malignant neoplasm of prostate C61 ; Atherosclerotic heart disease of native coronary artery without angina pectoris I25.10 ; Hypothyroidism, unspecified E03.9 ; Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene E11.51 and Type 2 diabetes mellitus with diabetic neuropathy, unspecified E11.40</td></tr></tbody></table></div><h3><a name="id5" href="#toc">ASSESSMENTS</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Type 2 diabetes mellitus with hyperglycemia (ICD-10 - E11.65)</td><td/><td/><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Malignant neoplasm of prostate (ICD-10 - C61)</td><td/><td/><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Atherosclerotic heart disease of native coronary artery without angina pectoris (ICD-10 - I25.10)</td><td/><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Hypothyroidism, unspecified (ICD-10 - E03.9)</td><td/><td/><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene (ICD-10 - E11.51)</td><td/><td/><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic neuropathy, unspecified (ICD-10 - E11.40)</td><td/><td/><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">PLAN OF TREATMENT</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Losartan Potassium 100 MG</td><td>1 tablet Orally Once a day for 90 days</td><td>[REDACTED]</td><td/><td/></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 01:20:00 PM, [REDACTED]-7130, [REDACTED]</td></tr></tbody></table></div><br/><br/>
</body></html>